Pathology News

In a recent review article, a YSM pathologist described existing technologies for monitoring CAR T-cell therapy and important avenues for future research.

The Katz Lab in the Department of Pathology was recently awarded a National Institutes of Health grant to study the role of a protein called BOK in cell death of neurons.

Patho-DBiT uses DNA barcoding to map the spatial relationships of RNA and proteins, allowing for a full examination of RNA (some types have regulatory roles in cancer). The technology, created in the lab of Yale’s Rong Fan, is now licensed to Yale spin-out AtlasXomics. Dr. Fan is a member of Yale Cancer Center.

Dr. Katerina Politi on Yale Cancer Answers.

Researchers have discovered a new chemical compound that is potent against both drug-sensitive and drug-resistant strains of malaria.

A new, highly sensitive test for a cancer biomarker could allow more lung cancer patients to benefit from a recently FDA-approved chemotherapy.

David Klimstra, MD, has been appointed Professor of Pathology, effective October 1.

After a recent site visit, a Department of Pathology team is encouraged that Yale’s pending transition to the Epic Beaker laboratory information system will improve alignment, standardization, and efficiency by enabling access to all of a patient’s information in one place.

For the study, the researchers used a method known as single-cell multi-omics established by Fan, the Harold Hodgkinson Professor of Biomedical Engineering and of Pathology and a member of Yale Cancer Center.